Prepare for your visit

David Q Beversdorf

Behavioral Neurology & Neuropsychiatry · Columbia, MO · NPI 1639253982

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$2,997.24

in general payments reported to CMS, 2019-2025 · $19.69 in 2025

The $19.69 reported for 2025 was less than what a typical Behavioral Neurology & Neuropsychiatry provider received nationally (typical 2025 total: $153).

Who reported paying

General payments only, top 4 by amount.

Biogen, INC. $2,834.69
Sk Life Science, INC. $85.90
Genzyme Corporation $56.96
Novo Nordisk INC $19.69

Questions you might ask

I saw David Beversdorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/893439/david-q-beversdorf